Top Stock Reports for Visa, ExxonMobil & Pfizer
Top Stock Reports for Visa, ExxonMobil & Pfizer Zacks Investment Research
Covered in this story
Analyst targets on ExxonMobil
- Barclays: at $170 · target $206 by Nov 2027 · Overweight via MarketBeat
- Bernstein: at $170 · target $186 by Nov 2027 · Outperform via MarketBeat
- Morgan Stanley: at $180 · target $187 by Nov 2027 via GuruFocus
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $XOM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on ExxonMobil →Dalsna Finance is currently tracking 44 stories mentioning ExxonMobil, the earliest published 15 Jun 2026.
Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.